Clinical Trial Update: Japanese Pradaxa PMS, Long Term

View source ↗

Summary

Long-term Japanese Pradaxa post-marketing surveillance trial for atrial fibrillation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2022-04-06